| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Silverback Therapeutics, Inc. | Interim CEO and GC | Common Stock | 52,323 | $197,938 | $3.78 | 02 Sep 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SPRY | Silverback Therapeutics, Inc. | 02 Sep 2022 | 0 | $0 | 3 | Interim CEO and GC | 08 Sep 2022, 17:04 |